
PAASPort®
A tool to judge risk of bias in biomedical research
Identify potential sources of bias early and improve decision-making.

START YOUR JOURNEY TO ACCREDITATION
by getting detailed information about PAASPort®

Risks in early-stage biotech investment
As the recent cases illustrate, apparent or actual issues with data integrity and research rigor can damage not only reputation of individual scientists but also affect the value of companies, whether privately held or publicly traded.
PAASP introduces a new service for the investment community engaged in early-stage biotech:
PAASPort®-based assessment of investment opportunities for data integrity and research rigor risks.
PAASP NETWORK PARTNERS ARE SUPPORTED BY
Funder of EQIPD from the Innovative Medicines Initiative 2 Joint Undertaking.
Conferrer of the NIDA Challenge Award and SBIR Grant for PAASPort®.
United States sponsor of the Global Preclinical Data Forum and sponsor of the Negative Data Prize and PEERS project.
PARTNER ORGANIZATIONS
A taste of our most recent headlines.
The EQIPD Quality System was presented at the World Conference on Research Integrity
June 16, 2022The World Conference on Research Integrity in 2022 happened in Cape Town, South Africa from May 29 to June 01. The…
Read MoreFirst International Society for Preclinical Research Quality Systems Launched
June 16, 2022The Guarantors of EQIPD e.V. (GoEQIPD) announce the formation of a registered association, registered in Heidelberg Germany, to host and to ensure…
Read MoreEQIPD-PAASP working relationship
June 16, 2022As an important step forward in the evolution of the EQIPD quality system for preclinical research, the Guarantors of EQIPD and the PAASP Network are…
Read More